
Onco, Journal Year: 2025, Volume and Issue: 5(2), P. 24 - 24
Published: May 9, 2025
Globally, women’s cancer-related morbidity and death are still caused mainly by gynecologic cancer. Antioxidant anti-inflammatory drugs have shown promise in treating cancer because of the complex interactions among oxidative stress, inflammation, development tumors. This review focuses on how these drugs, which include polyphenols, terpenoids, thiols-related phytochemical-derived compounds target different pathways associated with developing progressing We investigate what factors affect tumor microenvironment, specifically they immunological response vasculogenesis. Through recent studies, we gained an extensive understanding molecular that antioxidant use to achieve their therapeutic benefits. Gynecologic is a potent cause deaths fatalities for women globally.
Language: Английский